Dr. Suraj Perera (Sri Lanka) detailed the national cancer registry, which captures data from diagnosis and treatment, with limited mortality data from one district. Nine main cancer centers operate nationally, with plans for a comprehensive oncology center in each district and province. Data collection relies on the CanReg5 software and pathology reports, but challenges include […]
Country: Sri Lanka
Data reporting and collection mechanism for HPV vaccination program and the research gaps to improve health information system – Sri Lanka
Sri Lanka delivers HPV vaccination mainly via school-based programs integrated into primary health care, coordinated by the Epidemiology Unit with provincial and district health authorities. Data collection is paper-based at school level (school registers and child health records) and aggregated into the ENIP system (DHIS2 platform) for national monitoring. Public Health Inspectors conduct annual school […]
HPV vaccine roll-out in Sri Lanka; lessons learned from planning process
Sri Lanka’s HPV vaccine introduction process began with extensive evidence generation in 2009, including studies on HPV prevalence, genotype distribution, and cervical cancer burden. Cost analyses evaluated screening and treatment expenses, vaccination strategies (age, campaign vs. routine, school vs. community), and program feasibility. After initial rejection in 2010 due to high vaccine costs, a 2015 […]
HPV related disease burden, mortality, social and economic impact – Sri Lanka
Dr. Suraj Perera (Sri Lanka) presented national data on HPV-related cancers, noting that cervical cancer remains the leading HPV-associated cancer among Sri Lankan women. Using cancer registry data (capturing 90–95% of cases), he showed rising overall cancer incidence, with cervical cancer rates at 9.9 per 100,000 in 2019. Screening is offered twice (ages 35 and […]